BOSTON — Chemspeed Technologies and SciY introduced a new open Self-Driving Laboratory platform at SLAS2026, aiming to accelerate research and development, quality control, and chemical and biomolecular manufacturing by integrating automation, analytics, lab management software, and AI orchestration on a single, vendor-agnostic backbone.
The companies said the platform is designed to address common challenges in modern laboratories, where siloed tools and fragmented hardware and software environments often limit efficiency, scalability, and data connectivity. These integration gaps can slow discovery, development, and quality control processes and make it difficult for organizations to transition toward autonomous, AI-enabled operations.
The Self-Driving Laboratory platform brings together modular precision automation for R&D and QC, scientific analysis and lab management software, full lab digitization, and an AI-ready open data backbone. According to the companies, the approach enables autonomous, AI-orchestrated experimentation across heterogeneous lab environments without locking users into proprietary systems.
Advanced analytics capabilities support techniques such as NMR, IR and Raman spectroscopy, mass spectrometry, and X-ray analysis, providing traceable and quantitative data to support critical decision-making. Precision automation is intended to deliver reproducible and deterministic execution of complex workflows, while the open data backbone unifies instrument and robotics data, workflow orchestration, and FAIR data capture, curation, governance, and ontology-driven semantics.
“Vendor-agnostic orchestration is key,” said Bernd Gleixner, president of Chemspeed. “With our open Self-Driving Lab platform, we enable decision-making in closed-loop design–make–test–analyze workflows toward continuous, 24/7 operations. We are delivering not only a platform, but a service engine that accelerates discovery, supports compliant scale-up, and increases throughput across customers’ value chains.”
“We are seeing strong market interest from leading pharmaceutical partners,” said Santi Dominguez, president of SciY. “This confirms that customers are looking for open, readily deployable full-stack self-driving laboratories, and we are partnering with them to scale autonomous operations across sites and use cases.”
Chemspeed and SciY operate as vendor-agnostic divisions of Bruker Corporation.
